Cargando…
Cancer immunity and immunotherapy beyond COVID-19
Autores principales: | Bellone, Matteo, Brevi, Arianna, Bronte, Vincenzo, Dusi, Silvia, Ferrucci, Pier Francesco, Nisticò, Paola, Rosato, Antonio, Russo, Vincenzo, Sica, Antonio, Toietta, Gabriele, Colombo, Mario Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061391/ https://www.ncbi.nlm.nih.gov/pubmed/36995489 http://dx.doi.org/10.1007/s00262-023-03411-9 |
Ejemplares similares
-
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020
por: Bellone, Matteo, et al.
Publicado: (2022) -
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy
por: Bellone, Matteo, et al.
Publicado: (2021) -
The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma
por: Brevi, Arianna, et al.
Publicado: (2022) -
Strategies for Efficient Targeting of Tumor Collagen for Cancer Therapy
por: Baldari, Silvia, et al.
Publicado: (2022) -
What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO)
por: Ascierto, Paolo Antonio, et al.
Publicado: (2016)